Brief: MicroSalt Says Unexpected US FDA Focus Resulted In Adjusting Co's 2025 Sales Estimate To $2.0 Mln
18/08/2025 07:45
Aug 18 (Reuters) - MicroSalt PLC SALT.L: MICROSALT PLC - H1 2025 TRADING UPDATE MICROSALT: UNEXPECTED FOCUS BY US FDA ON ELIMINATION OF PETROLEUM-BASED FOOD COLOURING DELAYED LARGER ROLLOUT FROM Q4 2025 INTO 2026 MICROSALT PLC - UNEXPECTED US FDA FOCUS HAS RESULTED IN CO ADJUSTING ITS 2025 SALES ESTIMATE TO $2.0M Source text: ID:nRSR6916Va Further company coverage: SALT.L ((( Reuters.Briefs@thomsonreuters.com );))